Filter
2697
Filtered Results: 2697
Text search:
The
ORS
Featured
Recommendations
312
New Publications
563
Language
Document type
No document type
939
Guidelines
562
Studies & Reports
550
Manuals
264
Training Material
118
Strategic & Response Plan
109
Fact sheets
81
Infographics
24
Situation Updates
22
Brochures
17
Resource Platforms
7
Online Courses
2
App
1
Videos
1
Countries / Regions
India
169
Global
146
Kenya
97
South Africa
72
Nepal
66
Nigeria
59
Ethiopia
57
Uganda
57
Sierra Leone
51
Malawi
45
Liberia
39
Tanzania
38
Latin America and the Carribbean
38
Western and Central Europe
38
Rwanda
37
Bangladesh
36
Africa
32
Ghana
27
Haiti
25
Senegal
22
Ukraine
20
Myanmar / Burma
20
Zambia
19
Namibia
19
Zimbabwe
18
Philippines
18
Syria
17
Burkina Faso
16
Cambodia
15
South–East Asia Region
15
Eastern Europe and Central Asia
15
Brazil
14
Mozambique
13
Congo, Democratic Republic of
12
Indonesia
12
Lesotho
12
South Sudan
11
Eswatini/ Swaziland
10
Yemen
10
East and Southern Africa
10
Germany
9
West and Central Africa
9
Middle East and North Africa
9
Somalia
8
Botswana
8
Guinea
7
Cameroon
7
Afghanistan
7
Sudan
7
Venezuela
7
North America
7
Central African Republic
6
Mexico
6
Western Pacific Region
6
Eastern Europe
6
United Kingdom
6
Pakistan
5
Lebanon
5
Asia
5
Palestine
5
Laos
5
Moldova
5
Mali
4
China
4
Colombia
4
Madagascar
4
Russia
4
Vietnam
4
Côte d’Ivoire / Ivory Coast
3
Niger
3
Turkey
3
Thailand
3
Papua New Guinea
3
Benin
3
Libya
3
Tajikistan
3
Kyrgyzstan
3
Portugal
3
Guinea-Bissau
2
Morocco
2
Togo
2
Iraq
2
Jordan
2
Ireland
2
Argentina
2
North Macedonia
2
Hungary
2
Ecuador
2
Angola
2
Sri Lanka
2
Chile
2
Paraguay
2
Italy
2
Mongolia
2
Southern Africa
2
Iran
2
Kazakhstan
2
Gabon
2
Tunisia
2
Bosnia and Herzegovina
2
USA
1
Egypt
1
Chad
1
Malaysia
1
Singapore
1
Peru
1
Guatemala
1
Other region
1
Poland
1
Armenia
1
Estonia
1
Romania
1
Uzbekistan
1
Australia
1
Georgia
1
Turkmenistan
1
Jamaica
1
Belgium
1
Mauritius
1
Norway
1
Spain
1
French Guyana
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
1100
Clinical Guidelines
253
Women & Child Health
211
Public Health
171
Key Resources
130
Capacity Building
78
Pharmacy & Technologies
27
Annual Report MEDBOX
1
Toolboxes
COVID-19
378
Caregiver
134
Mental Health
133
HIV
107
Planetary Health
105
AMR
101
Rapid Response
91
Cholera
81
NCDs
74
Pharmacy
70
NTDs
69
Conflict
61
Ebola
59
TB
59
Refugee
57
Disability
45
Social Ethics
30
Natural Hazards
27
Global Health Education
23
Health Financing Toolbox
18
Zika
11
Specific Hazards
10
Polio
8
Health Financing
1
The burden of diabetes is enormous, positioning it as one of the main challenges facing public health today. Currently, it is estimated that 62 million people are living with diabetes in ... Region of the Americas and projections show its prevalence will continue rising over the following years. The Region shows the highest number of years of healthy life lost (through either disability or premature death) due to diabetes worldwide. The high costs associated with its treatment produce a heavy economic burden. Its complications can seriously affect the quality of life of people living with diabetes, their families, and society and overload health systems. This report shows the latest internationally comparable data on diabetes and its main risk factors by year, country, and sex. It also includes a summary of the countries health systems’ response to diabetes, including national plans, targets, surveillance, guidelines, and access to essential drugs and technologies, and synthesizes information about diabetes-related complications and the close relationship between diabetes and other pathologies, such as cardiovascular diseases, tuberculosis, and COVID-19. The data presented here reveal that, despite advances in national responses, diabetes continues to expand, and our response remains insufficient. This report aims to draw attention to the urgent need to strengthen efforts to prevent, diagnose, and control diabetes in the Region of the Americas.
The Resolution Population and Individual Approaches to the Prevention and Management of Diabetes and Obesity was approved by the 48th Directing Cou...
The Global Action Plan for the Prevention and Control of Noncommunicable Diseases 2013-2020 by the World Health Organization (WHO) outlines a compr...
The "Assessing National Capacity for the Prevention and Control of Noncommunicable Diseases: Report of the 2021 Global Survey" by WHO examines ... global state of readiness and infrastructure for managing noncommunicable diseases (NCDs) across countries. Based on the 2021 survey, it analyzes national capabilities in public health infrastructure, policies, health systems, and the impact of the COVID-19 pandemic on NCD-related resources. The report highlights gaps and strengths in NCD prevention, treatment, and health policy integration, offering insights for improving NCD care worldwide. It emphasizes the need for multisectoral collaboration and targeted actions to meet global health goals.
The WHO document "Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance" provides a fra...
This review examines high-quality research evidence that synthesises the efects of extreme heat on human health in tropical
Africa. Web of Science (WoS) was used to identify research articles on the...
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines ... effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health systems to anticipate and mitigate stresses across NCD medicine supply chains. The full range of upstream and downstream impacts are investigated, including: manufacturing; procurement, importation and last mile delivery; patient-level effects through affordability and availability; and the effects on NCD medicine availability by category of disease. The report culminates in recommended actions and interventions for key stakeholders in the NCD pharmaceutical supply chain, including governments, regulatory authorities, manufacturers and the private sector; as well as directions for future research for improving access and supply chain access resilience.
This UNAIDS 2024 report brings together new data and case studies which demonstrate that the decisions and policy choices taken by world leaders this year will decide the fate of millions of lives a...
The Global Asthma Report (GAR) 2022, prepared by the Global Asthma Network (GAN), is the fourth such report (others 2011, 2014, 2018). GAN builds u...
The pharmacological management of asthma has changed considerably in recent decades, as it has come to be understood that it is a complex, heterogeneous disease with different phenotypes and endotypes. It is now clear that ... goal of asthma treatment should be to achieve and maintain control of the disease, as well as to minimize the risks (of exacerbations, disease instability, accelerated loss of lung function, and adverse treatment effects). That requires an approach that is personalized in terms of the pharmacological treatment, patient education, written action plan, training in correct inhaler use, and review of the inhaler technique at each office visit. A panel of 22 pulmonologists was invited to perform a critical review of recent evidence of pharmacological treatment of asthma and to prepare this set of recommendations, a treatment guide tailored to use in Brazil. The topics or questions related to the most significant changes in concepts, and consequently in the management of asthma in clinical practice, were chosen by a panel of experts. To formulate these recommendations, we asked each expert to perform a critical review of a topic or to respond to a question, on the basis of evidence in the literature. In a second phase, three experts discussed and structured all texts submitted by the others. That was followed by a third phase, in which all of the experts reviewed and discussed each recommendation. These recommendations, which are intended for physicians involved in the treatment of asthma, apply to asthma patients of all ages.
Since there is no single objective diagnostic test for asthma this study suggests an approach of collecting and assembling pieces of clinical information to create a diagnostic picture, like making a jigsaw puzzle. These pieces should include demonstration of symptom and airway variability and/or br...
The social protection landscape for people affected by TB in the WHO South-East Asia Region
The target audience of this document (and the associated online companion tool) includes WHO country offices
in Member States of the African Regi...
Biology, Diagnosis and Treatment, Epidemiology and Prevention
Integrated management of childhood illness. The last update was in the IMCI chart booklet in 2014, but since then there have been significant updates on t... management of sick young infant (SYI) aged up to 2 months. This 2019 update of the sick young infant section Management of the sick young infant age up to 2 months: IMCI chart booklet. supersedes the 2014 IMCI chart booklet. The new updates reflect the recent guidelines on Managing possible serious bacterial infection (PSBI) in young infants when referral is not feasible published in 2015. It includes assessment, classification and referral of SYI with PSBI; and outpatient treatment of SYI with local infection or fast breathing (pneumonia) in infants 7-59 days old. Other updates include: a new section on how to reassess, classify and treat SYI with PSBI when referral is not feasible in outpatient health facilities by IMNCI trained health workers; changes in assessment and management of young infants for HIV infection; and identification of infants less than 7 days of who need Kangaroo Care.
